Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Theuns

Showing results (111-120 of 173) with videos related to

Pageof 18
Sort By:
Pacing and Clinical Electrophysiology : PACE|February 25, 2012
Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: design and rationale of the EFFORTLESS S-ICD RegistrySusanne S Pedersen, Pier Lambiase, Lucas V A Boersma, et al.
European Heart Journal|June 3, 2008
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure SurveyMaximo Rivero-Ayerza, Wilma Scholte Op Reimer, Mattie Lenzen, et al.
The American Journal of Cardiology|July 31, 2007
Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiologyOsama I I Soliman, Dominic A M J Theuns, Folkert J ten Cate, et al.
Journal of Cardiac Failure|September 4, 2019
Predicting Early Mortality Among Implantable Defibrillator Patients Treated With Cardiac Resynchronization TherapyDominic A M J Theuns, Nick Van Boven, Beat A Schaer, et al.
International Journal of Cardiology|February 13, 2020
Prevalence of anxiety and risk associated with ventricular arrhythmia in patients with an implantable cardioverter defibrillatorM Habibović, S S Pedersen, E R Broers, et al.
Neurobiology of Aging|May 27, 2005
Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's diseaseR Rademakers, K Sleegers, J Theuns, et al.
Cardiology|January 21, 2021
Incremental Value of an Insertable Cardiac Monitor in Patients with Hypertrophic Cardiomyopathy with Low or Intermediate Risk for Sudden Cardiac DeathRafi Sakhi, Roy Huurman, Dominic A M J Theuns, et al.
Trials|December 25, 2009
Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of lifeSusanne S Pedersen, Viola Spek, Dominic A M J Theuns, et al.
The American Journal of Cardiology|June 30, 2016
A Comparison of the Quality of Life of Patients With an Entirely Subcutaneous Implantable Defibrillator System Versus a Transvenous System (from the EFFORTLESS S-ICD Quality of Life Substudy)Susanne S Pedersen, Mirjam H Mastenbroek, Nathan Carter, et al.
Neurology|October 8, 2008
Progranulin variability has no major role in Parkinson disease genetic etiologyK Nuytemans, P Pals, K Sleegers, et al.
Pageof 18

Showing results (111-120 of 173) with videos related to

Sort By:
Pageof 18
Pacing and Clinical Electrophysiology : PACE|February 25, 2012
Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: design and rationale of the EFFORTLESS S-ICD RegistrySusanne S Pedersen, Pier Lambiase, Lucas V A Boersma, et al.
European Heart Journal|June 3, 2008
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure SurveyMaximo Rivero-Ayerza, Wilma Scholte Op Reimer, Mattie Lenzen, et al.
The American Journal of Cardiology|July 31, 2007
Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiologyOsama I I Soliman, Dominic A M J Theuns, Folkert J ten Cate, et al.
Journal of Cardiac Failure|September 4, 2019
Predicting Early Mortality Among Implantable Defibrillator Patients Treated With Cardiac Resynchronization TherapyDominic A M J Theuns, Nick Van Boven, Beat A Schaer, et al.
International Journal of Cardiology|February 13, 2020
Prevalence of anxiety and risk associated with ventricular arrhythmia in patients with an implantable cardioverter defibrillatorM Habibović, S S Pedersen, E R Broers, et al.
Neurobiology of Aging|May 27, 2005
Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's diseaseR Rademakers, K Sleegers, J Theuns, et al.
Cardiology|January 21, 2021
Incremental Value of an Insertable Cardiac Monitor in Patients with Hypertrophic Cardiomyopathy with Low or Intermediate Risk for Sudden Cardiac DeathRafi Sakhi, Roy Huurman, Dominic A M J Theuns, et al.
Trials|December 25, 2009
Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of lifeSusanne S Pedersen, Viola Spek, Dominic A M J Theuns, et al.
The American Journal of Cardiology|June 30, 2016
A Comparison of the Quality of Life of Patients With an Entirely Subcutaneous Implantable Defibrillator System Versus a Transvenous System (from the EFFORTLESS S-ICD Quality of Life Substudy)Susanne S Pedersen, Mirjam H Mastenbroek, Nathan Carter, et al.
Neurology|October 8, 2008
Progranulin variability has no major role in Parkinson disease genetic etiologyK Nuytemans, P Pals, K Sleegers, et al.
Pageof 18